SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-20-008291
Filing Date
2020-04-01
Accepted
2020-04-01 08:37:57
Documents
2
Period of Report
2020-03-31
Items
Item 5.05: Amendments to the Registrant's Code of Ethics, or Waiver of a Provision of the Code of Ethics
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea120276-8k_citiuspharm.htm 8-K 21827
2 PRESS RELEASE DATED APRIL 1, 2020. ea12027ex99-1_citiuspharm.htm EX-99.1 11986
  Complete submission text file 0001213900-20-008291.txt   35213
Mailing Address 11 COMMERCE DRIVE 1ST FLOOR CRANFORD NJ 07016
Business Address 11 COMMERCE DRIVE 1ST FLOOR CRANFORD NJ 07016 (908) 967-6676
Citius Pharmaceuticals, Inc. (Filer) CIK: 0001506251 (see all company filings)

IRS No.: 273425913 | State of Incorp.: NV | Fiscal Year End: 0930
Type: 8-K | Act: 34 | File No.: 001-38174 | Film No.: 20763818
SIC: 2834 Pharmaceutical Preparations